Search research articles
Contact Us
Filters
Showing results (71-80 of 225) with videos related to
Page
of 23
Sort By:
Neuro-Oncology
|
December 25, 2010
APO010, a synthetic hexameric CD95 ligand, induces human glioma cell death in vitro and in vivo
Günter Eisele, Patrick Roth, Kathy Hasenbach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 23, 2017
NKG2D-Dependent Antitumor Effects of Chemotherapy and Radiotherapy against Glioblastoma
Tobias Weiss, Hannah Schneider, Manuela Silginer, et al.
Neuro-Oncology
|
July 30, 2022
Improved seizure control in patients with recurrent glioblastoma treated with bevacizumab
Caroline Hertler, Katharina Seystahl, Emilie Le Rhun, et al.
Molecular Cancer Therapeutics
|
April 6, 2017
Biological Role and Therapeutic Targeting of TGF-β<sub>3</sub> in Glioblastoma
Katharina Seystahl, Alexandros Papachristodoulou, Isabel Burghardt, et al.
Nature Reviews. Neurology
|
May 13, 2017
Vaccine-based immunotherapeutic approaches to gliomas and beyond
Michael Weller, Patrick Roth, Matthias Preusser, et al.
European Journal of Neurology
|
May 12, 2022
Venous thromboembolic events in glioblastoma patients: An epidemiological study
Amanda Eisele, Katharina Seystahl, Elisabeth J Rushing, et al.
Neuro-Oncology
|
June 19, 2021
Increase in contrast-enhancing volume of irradiated meningiomas reflects tumor progression and not pseudoprogression
Hans-Georg Wirsching, Lea Steiner, Denise Becker, et al.
Journal of Neurochemistry
|
May 9, 2012
Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells
Caroline Happold, Patrick Roth, Wolfgang Wick, et al.
International Journal of Cancer
|
May 11, 2013
αv-Integrin isoform expression in primary human tumors and brain metastases
Alexander Vogetseder, Svenja Thies, Barbara Ingold, et al.
Journal of Neurosurgery
|
December 8, 2009
Soluble CD70: a novel immunotherapeutic agent for experimental glioblastoma
James Miller, Guenter Eisele, Ghazaleh Tabatabai, et al.
Page
of 23
Search research articles
Search
Showing results (71-80 of 225) with videos related to
Sort By:
Page
of 23
Neuro-Oncology
|
December 25, 2010
APO010, a synthetic hexameric CD95 ligand, induces human glioma cell death in vitro and in vivo
Günter Eisele, Patrick Roth, Kathy Hasenbach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 23, 2017
NKG2D-Dependent Antitumor Effects of Chemotherapy and Radiotherapy against Glioblastoma
Tobias Weiss, Hannah Schneider, Manuela Silginer, et al.
Neuro-Oncology
|
July 30, 2022
Improved seizure control in patients with recurrent glioblastoma treated with bevacizumab
Caroline Hertler, Katharina Seystahl, Emilie Le Rhun, et al.
Molecular Cancer Therapeutics
|
April 6, 2017
Biological Role and Therapeutic Targeting of TGF-β<sub>3</sub> in Glioblastoma
Katharina Seystahl, Alexandros Papachristodoulou, Isabel Burghardt, et al.
Nature Reviews. Neurology
|
May 13, 2017
Vaccine-based immunotherapeutic approaches to gliomas and beyond
Michael Weller, Patrick Roth, Matthias Preusser, et al.
European Journal of Neurology
|
May 12, 2022
Venous thromboembolic events in glioblastoma patients: An epidemiological study
Amanda Eisele, Katharina Seystahl, Elisabeth J Rushing, et al.
Neuro-Oncology
|
June 19, 2021
Increase in contrast-enhancing volume of irradiated meningiomas reflects tumor progression and not pseudoprogression
Hans-Georg Wirsching, Lea Steiner, Denise Becker, et al.
Journal of Neurochemistry
|
May 9, 2012
Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells
Caroline Happold, Patrick Roth, Wolfgang Wick, et al.
International Journal of Cancer
|
May 11, 2013
αv-Integrin isoform expression in primary human tumors and brain metastases
Alexander Vogetseder, Svenja Thies, Barbara Ingold, et al.
Journal of Neurosurgery
|
December 8, 2009
Soluble CD70: a novel immunotherapeutic agent for experimental glioblastoma
James Miller, Guenter Eisele, Ghazaleh Tabatabai, et al.
Page
of 23